Circulating Tumor DNA (ctDNA) Testing to Predict Response in Solid Tumors

Characterizing molecular material from solid tumors using body fluids, such as blood, urine, and cerebrospinal fluid, rather than invasive biopsies, represents a major advancement in oncology.1 One of the most widely studied forms of liquid…

Continue Reading